Brian [18F]FDG PET associations of cervical cancer-related peripheral inflammatory markers

Brian [18F]FDG PET associations of cervical cancer-related peripheral inflammatory markers

ObjectiveThe purpose of this study was to explore brain metabolic correlates of peripheral inflammatory markers in patients with cervical cancer (CC).MethodsCervical cancer (CC) patients (267) without treatments who underwent [18F] Fluorodeoxyglucose ([18F]FDG) positron-emission tomography (PET)/com...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yao Hu, Yuan Zhong, Yuxiao Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Oncology
Subjects:	regional brain glucose metabolism cervical cancer peripheral inflammatory markers tumor metabolic parameters PET
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1598911/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between appendicular skeletal muscle mass and myocardial glucose uptake measured by 18F‐FDG PET
by: Young‐eun Kim, et al.
Published: (2025-02-01)

[<sup>18</sup>F]FDG PET/CT of Langerhans Cell Histiocytosis with Vertebra Plana
by: Tilman Speicher, et al.
Published: (2025-03-01)

Changes in cerebral glucose metabolism among mild long COVID patients: an [18F]FDG PET/CT study
by: J.S. Sakamoto, et al.
Published: (2024-11-01)

SSB expression is associated with metabolic parameters of 18F-FDG PET/CT in lung adenocarcinoma and can improve diagnostic efficiency
by: Zi-Yue Liu, et al.
Published: (2024-11-01)

Global glucose metabolism rate as diagnostic marker for disorder of consciousness of patients: quantitative FDG-PET study
by: Dongsheng Liu, et al.
Published: (2025-01-01)

Altered frontotemporal glucose metabolism following radiotherapy and/or chemotherapy for cervical cancer
by: Yao Hu, et al.
Published: (2025-06-01)

Brain-thyroid crosstalk: 18F-FDG-PET/MRI evidence in patients with follicular thyroid adenomas
by: Yun-Ting Xiang, et al.
Published: (2025-05-01)

Enhanced glucose metabolism mediated by CD147 is associated with 18F‐FDG PET/CT imaging in lung adenocarcinoma
by: Yufan Zhang, et al.
Published: (2020-05-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

[18F]-FDG PET-CT in Malignant Melanoma
by: Teodora Sidonia Mititelu, et al.
Published: (2025-05-01)

The clinical features and 18F-FDG-PET analysis of absence status epilepsy
by: Jing-Wen Zuo, et al.
Published: (2025-05-01)

Comparative Diagnostic Value of 18F-FDG–PET–CT and Intraoperative Examination in Cervical Cancer Staging
by: Goran Malenković, et al.
Published: (2024-10-01)

[<sup>18</sup>F]FDG PET/CT Radiomics in Cervical Cancer: A Systematic Review
by: Judicael Hotton, et al.
Published: (2024-12-01)

The baseline 18F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma
by: Keyu Zhang, et al.
Published: (2025-08-01)

Non-[<sup>18</sup>F]FDG PET-Radiopharmaceuticals in Oncology
by: Antonia Dimitrakopoulou-Strauss, et al.
Published: (2024-12-01)

Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment 18F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer
by: Mimi Xu, et al.
Published: (2025-02-01)

18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
by: Tine Gadegaard Hindso, et al.
Published: (2025-02-01)

The predictive power of baseline metabolic and volumetric [18F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapy
by: Emil Novruzov, et al.
Published: (2025-06-01)

Predicting Glioma Recurrence Using 18F-FDG PET/CT, MRI, and Tumor Markers: A Combined Approach
by: Wei J
Published: (2025-05-01)

Predictive significance of 18F-FDG PET/CT metabolic parameters for the expression level of HER2 in gastric cancer
by: Zhang Shilai, et al.
Published: (2025-04-01)

The Combined Prognostic Value of 18F‐FDG PET/CT Metabolic Parameters of Immune Organs and Hematological Immune‐Related Markers in Patients With Locally Advanced Cervical Cancer
by: Yi Li, et al.
Published: (2025-02-01)

BRAIN-TO-LIVER RATIO FROM 18F-FDG-PET/CT AS A PROGNOSTIC MARKER IN MULTIPLE MYELOMA
by: Tiago Pessolo Dos Santos, et al.
Published: (2025-05-01)

Alterations in cerebral glucose metabolism measured by FDG PET in subjects performing a meditation practice based on clitoral stimulation [version 2; peer review: 2 approved, 1 approved with reservations]
by: Nancy A. Wintering, et al.
Published: (2023-12-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
by: Shiqing Liu, et al.
Published: (2025-08-01)

Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
by: Alexander Brose, et al.
Published: (2024-12-01)

Diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in preoperative staging of locoregional urinary bladder cancer: a systematic review and Meta-Analysis
by: Ahmed Saad Abdlkadir, et al.
Published: (2025-07-01)

18F-FDG PET/CT findings of intermediate bone tumors of the spine
by: Xianwen Hu, et al.
Published: (2025-04-01)

COMPARISON BETWEEN 18F-PSMA AND 18F-FDG RADIOTRACERS FOR PET/CT IN THE EVALUATION OF PATIENTS WITH METASTATIC MELANOMA
by: Thiago Soare Rocha Alves, et al.
Published: (2025-05-01)

Harnessing unsupervised machine learning with [18F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Jinyu Shi, et al.
Published: (2025-05-01)

Comparative Imaging Analysis of Kimura&rsquo;s Disease Using 18F-FDG PET/CT and [18F]AlF-NOTA-FAPI-04 PET/CT
by: Sun C, et al.
Published: (2025-05-01)

18F-FDG PET/CT metabolic parameters are correlated with clinical features and valuable in clinical stratification management in patients of castleman disease
by: Guolin Wang, et al.
Published: (2025-02-01)

Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
by: Yousif A. Lucinian, et al.
Published: (2022-12-01)

In-ovo imaging using ostrich eggs: biodistribution of F-18-FDG in ostrich embryos
by: Thomas Winkens, et al.
Published: (2025-06-01)

[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
by: Dandan Yu, et al.
Published: (2025-01-01)

DUAL-TRACER PET/CT IMAGING IN HEPATOCELLULAR CARCINOMA: COMPARING THE PERFORMANCE OF 18F-FDG AND 18F-PSMA
by: Giulia Picciola Bordoni, et al.
Published: (2025-05-01)

18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
by: Teik Hin Tan, et al.
Published: (2022-06-01)

Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
by: Padma Subramanyam, et al.
Published: (2020-07-01)

Application of <sup>18</sup>F-FDG Positron Emission Tomography/Magnetic Resonance in Evaluation of Oropharyngeal Carcinoma
by: Yilin Shen, et al.
Published: (2025-04-01)

2‐[18F] FDG PET/CT in Rapid Late‐Onset Multiple Acyl‐CoA Dehydrogenase Deficiency: A Case Report
by: Astrid Høj, et al.
Published: (2025-03-01)

THE DIAGNOSTIC ROLE OF 18F-FDG-PET/CT IN PATIENTS WITH CONSTITUTIONAL SYMPTOMS
by: Mustafa Altınkaynak, et al.
Published: (2023-03-01)